T-Cell Receptor Therapy in the Treatment of Ovarian Cancer: A Mini Review
Ovarian cancer, in particularly high-grade serous ovarian cancer (HGSOC) and ovarian carcinosarcoma (OCS), are highly aggressive and deadly female cancers with limited treatment options. These tumors are generally unresponsive to immune check-point inhibitor (ICI) therapy and are referred to as immu...
Hlavní autoři: | Jessica W. Y. Wu, Sudiksha Dand, Lachlan Doig, Anthony T. Papenfuss, Clare L. Scott, Gwo Ho, Joshua D. Ooi |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
Frontiers Media S.A.
2021-04-01
|
Edice: | Frontiers in Immunology |
Témata: | |
On-line přístup: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.672502/full |
Podobné jednotky
-
A library-based screening method identifies neoantigen-reactive T cells in peripheral blood prior to relapse of ovarian cancer
Autor: Spencer D. Martin, a další
Vydáno: (2018-01-01) -
A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma
Autor: Apostolos Sarivalasis, a další
Vydáno: (2019-11-01) -
Neoantigen‐reactive T cell: An emerging role in adoptive cellular immunotherapy
Autor: Yicheng Zhu, a další
Vydáno: (2021-06-01) -
Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer
Autor: Song Liu, a další
Vydáno: (2019-06-01) -
Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer
Autor: John Nemunaitis, a další
Vydáno: (2023-09-01)